JP2025501452A5 - - Google Patents
Info
- Publication number
- JP2025501452A5 JP2025501452A5 JP2024533052A JP2024533052A JP2025501452A5 JP 2025501452 A5 JP2025501452 A5 JP 2025501452A5 JP 2024533052 A JP2024533052 A JP 2024533052A JP 2024533052 A JP2024533052 A JP 2024533052A JP 2025501452 A5 JP2025501452 A5 JP 2025501452A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- sequence described
- binding substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288162P | 2021-12-10 | 2021-12-10 | |
| US63/288,162 | 2021-12-10 | ||
| PCT/US2022/081253 WO2023108114A2 (en) | 2021-12-10 | 2022-12-09 | Human mesothelin binders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501452A JP2025501452A (ja) | 2025-01-22 |
| JP2025501452A5 true JP2025501452A5 (https=) | 2025-12-15 |
Family
ID=86731328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533052A Pending JP2025501452A (ja) | 2021-12-10 | 2022-12-09 | ヒトメソテリン結合物質 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4444757A4 (https=) |
| JP (1) | JP2025501452A (https=) |
| KR (1) | KR20240114766A (https=) |
| CN (1) | CN118660911A (https=) |
| AU (1) | AU2022407541A1 (https=) |
| CA (1) | CA3239553A1 (https=) |
| MX (1) | MX2024007054A (https=) |
| WO (1) | WO2023108114A2 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2526355T3 (es) * | 2007-10-01 | 2015-01-09 | Bristol-Myers Squibb Company | Anticuerpos humanos que se adhieren a mesotelina, y usos de los mismos |
| BR112013014527A2 (pt) * | 2010-12-20 | 2017-03-07 | Genentech Inc | anticorpo isolado, ácido nucleico isolado, célula hospedeira, método para produzir um anticorpo, imunoconjugado, formulação farmacêutica, uso do imunoconjugado, método para tratamento de um indivíduo que tem um câncer positivo para mesotelina, para inibição de proliferação de uma célula positiva para mesotelina, para detecção de mesotelina humana em uma amostra biológica e para detectar um câncer positivo para mesotelina |
| WO2014004549A2 (en) * | 2012-06-27 | 2014-01-03 | Amgen Inc. | Anti-mesothelin binding proteins |
| WO2018209304A1 (en) * | 2017-05-12 | 2018-11-15 | Harpoon Therapeutics, Inc. | Msln targeting trispecific proteins and methods of use |
| GB201811450D0 (en) * | 2018-07-12 | 2018-08-29 | F Star Delta Ltd | Mesothelin and CD137 binding molecules |
| SG11202106764YA (en) * | 2018-12-27 | 2021-07-29 | Gigagen Inc | Anti-ctla-4 binding proteins and methods of use thereof |
| KR20220047536A (ko) * | 2019-04-01 | 2022-04-18 | 레이크파르마, 인코퍼레이티드 | 면역반응의 조절 및 질병의 치료를 위한 btla-결합(cd272) 항체 |
-
2022
- 2022-12-09 MX MX2024007054A patent/MX2024007054A/es unknown
- 2022-12-09 AU AU2022407541A patent/AU2022407541A1/en active Pending
- 2022-12-09 EP EP22905403.6A patent/EP4444757A4/en active Pending
- 2022-12-09 CA CA3239553A patent/CA3239553A1/en active Pending
- 2022-12-09 JP JP2024533052A patent/JP2025501452A/ja active Pending
- 2022-12-09 WO PCT/US2022/081253 patent/WO2023108114A2/en not_active Ceased
- 2022-12-09 CN CN202280090785.9A patent/CN118660911A/zh active Pending
- 2022-12-09 KR KR1020247022588A patent/KR20240114766A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP2023503180A (ja) | 抗ヒトクローディン１８．２抗体及びその適用 | |
| JP2023511774A5 (https=) | ||
| JP2021533726A5 (https=) | ||
| RU2012112340A (ru) | Гуманизированные моноклональные антитела к сеа с созревшей аффинностью | |
| JP2006506955A5 (https=) | ||
| JP2021525546A5 (https=) | ||
| JP2010504755A5 (https=) | ||
| KR920702425A (ko) | Cdr 이식된 항-cea 항체 및 그의 제조 | |
| JP2013524773A5 (https=) | ||
| JP2021524478A5 (https=) | ||
| RU2008126242A (ru) | Антитела против глобуломера а бета, их антигенсвязывающие части, соответствующие гибридомы, нуклеиновые кислоты, векторы, клетки-хозяева, способы получения указанных антител, композиции, содержащие указанные антитела, применения указанных антител и способы использования указанных антител | |
| RU2013125459A (ru) | АНТИТЕЛА ПРОТИВ БЕЛКА РЕЦЕПТОРА c-Met | |
| RU2004135103A (ru) | Антитела, специфичные к cd22 человека, и их применения в терапии и диагностике | |
| RU2011103125A (ru) | КОМБИНАЦИЯ АНТАГОНИСТА c-Met И АМИНОГЕТЕРОАРИЛА ДЛЯ ЛЕЧЕНИЯ РАКА | |
| JP2022532173A5 (https=) | ||
| JP2019205480A5 (https=) | ||
| JP2023549537A5 (https=) | ||
| JP2024541680A5 (https=) | ||
| JP2023548529A5 (https=) | ||
| JP2024016024A5 (https=) | ||
| CN114591434A (zh) | 抗Siglec15抗体及其制备方法和用途 | |
| JP2020531003A5 (https=) | ||
| JP2022517216A5 (https=) | ||
| JP2023517794A5 (https=) |